Shining a light on the evidence for hydroxychloroquine in SARS-CoV-2

被引：8

作者：

Ingraham, Nicholas E. ^{[1
]}

Boulware, David ^{[2
]}

Sparks, Matthew A. ^{[3
]}

Schacker, Timothy

Benson, Bradley ^{[4
]}

Sparks, Jeffrey A. ^{[5
,6
]}

Murray, Thomas ^{[7
]}

Connett, John ^{[7
]}

Chipman, Jeffrey G. ^{[8
]}

Charles, Anthony ^{[9
,10
]}

Tignanelli, Christopher J. ^{[10
,11
]}

机构：

[1] Univ Minnesota, Div Pulm & Crit Care, Dept Med, MMC 195,420 Delaware St SE, Minneapolis, MN 55455 USA

[2] Univ Minnesota, Dept Med, Div Infect Dis & Int Med, Box 736 UMHC, Minneapolis, MN 55455 USA

[3] Duke Univ, Dept Med, Div Nephrol, Durham, NC USA

[4] Univ Minnesota, Dept Med, Div Gen Internal Med, Box 736 UMHC, Minneapolis, MN 55455 USA

[5] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA

[6] Harvard Med Sch, Div Rheumatol Inflammat & Immun, Boston, MA 02115 USA

[7] Univ Minnesota, Sch Publ Hlth, Div Biostat, Minneapolis, MN 55455 USA

[8] Univ Minnesota, Dept Surg, Div Acute Care Surg, Box 242 UMHC, Minneapolis, MN 55455 USA

[9] Univ N Carolina, Sch Med, Dept Surg, Chapel Hill, NC 27515 USA

[10] Univ N Carolina, Sch Med, Sch Publ Hlth, Chapel Hill, NC 27515 USA

[11] Univ Minnesota, Inst Hlth Informat, Minneapolis, MN USA

来源：

CRITICAL CARE | 2020年 / 24卷 / 01期

关键词：

Evidence-based medicine; COVID-19; Hydroxychloroquine; Pandemic; RCT; SARS;

D O I：

10.1186/s13054-020-02894-7

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

引用

页数：2

共 7 条

[1]

Barnard Dale L., 2006, Antiviral Chemistry & Chemotherapy, V17, P275

[2] Design and synthesis of hydroxyferroquine derivatives with antimalarial and antiviral activities [J].

Biot, C ;

Daher, W ;

Chavain, N ;

Fandeur, T ;

Khalife, J ;

Dive, D ;

De Clercq, E .

JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (09) :2845-2849

[3]

Chen Jun, 2020, Zhejiang Da Xue Xue Bao Yi Xue Ban, V49, P215, DOI 10.3785/j.issn.1008-9292.2020.03.03

[4] Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial [J].

Gautret, Philippe ;

Lagier, Jean-Christophe ;

Parola, Philippe ;

Van Thuan Hoang ;

Meddeb, Line ;

Mailhe, Morgane ;

Doudier, Barbara ;

Courjon, Johan ;

Giordanengo, Valerie ;

Vieira, Vera Esteves ;

Dupont, Herve Tissot ;

Honore, Stephane ;

Colson, Philippe ;

Chabriere, Eric ;

La Scola, Bernard ;

Rolain, Jean-Marc ;

Brouqui, Philippe ;

Raoult, Didier .

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2020, 56 (01)

[5]

Gordon David E, 2020, bioRxiv, DOI 10.1101/2020.03.22.002386

[6] Chloroquine is a potent inhibitor of SARS coronavirus infection and spread [J].

Vincent, Martin J. ;

Bergeron, Eric ;

Benjannet, Suzanne ;

Erickson, Bobbie R. ;

Rollin, Pierre E. ;

Ksiazek, Thomas G. ;

Seidah, Nabil G. ;

Nichol, Stuart T. .

VIROLOGY JOURNAL, 2005, 2 (1)

[7] Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro [J].

Wang, Manli ;

Cao, Ruiyuan ;

Zhang, Leike ;

Yang, Xinglou ;

Liu, Jia ;

Xu, Mingyue ;

Shi, Zhengli ;

Hu, Zhihong ;

Zhong, Wu ;

Xiao, Gengfu .

CELL RESEARCH, 2020, 30 (03) :269-271

← 1 →